Skip to Main Content

Paper Details

De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome.
Med Oncol
16
2021
Chromogranin, Cyclin D1, CyclinD1, Ki67, NKX3, NT, PCA, PCA-, PCA-NT, PSA, RB, RB1, Synaptophysin, adenocarcinoma, androgen, carcinoma, high-grade prostate cancer, patients, primary prostate cancer
Author NameAffiliation
Arul M ChinnaiyanUniversity of Michigan Medical School ann arbor
Arul M ChinnaiyanHoward Hughes Medical Institute
Arul M ChinnaiyanMichigan Center for Translational Pathology
Arul M ChinnaiyanRogel Cancer Center
Arul M ChinnaiyanUniversity of Michigan Medical School ann arbor
Arul M ChinnaiyanUniversity of Michigan Medical School ann arbor
Arul M ChinnaiyanUniversity of Michigan Medical School ann arbor
Arul M ChinnaiyanRogel Cancer Center
Arul M ChinnaiyanMichigan Center for Translational Pathology
Arul M ChinnaiyanHoward Hughes Medical Institute
Lakshmi P KunjuUniversity of Michigan Medical School ann arbor
Todd M MorganUniversity of Michigan Medical School ann arbor
Joshi J AlumkalUniversity of Michigan ann arbor
Joshi J AlumkalRogel Cancer Center
Joshi J AlumkalMichigan Center for Translational Pathology
Daniel E SprattUniversity of Michigan Medical School ann arbor
Rohit MehraUniversity of Michigan Medical School ann arbor
Rohit MehraRogel Cancer Center
Rohit MehraMichigan Center for Translational Pathology
  • 1 - 19

Datasets

Release 1.2